VAERS Explorer
Back to explore

Report #2835543

Received Apr 10, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Female
Age
39 yrs
State
PA
Recovered
Not recovered
Vaccinated
Jun 1, 2023
Onset
Jun 1, 2023
Days to onset
0
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
VARZOSZOSTER (SHINGRIX)GLAXOSMITHKLINE BIOLOGICALS1UNKIM / RA

Symptoms (3)

COVID-19Herpes zosterProduct administered to patient of inappropriate age

Symptom narrative

COVID-19; currently has shingles now, APR 2025; Shingles NOV 2024; Shingles MAR 2024; Shingles Mild case in OCT-2023; 39 year old patient her first dose of Shingrix in June 2023; This non-serious case was reported by a consumer via call center representative and described the occurrence of shingles in a 39-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis. The patient's past medical history included shingles (had shingles 11 times with the first time at 19 years old). In JUN-2023, the patient received the 1st dose of Shingrix (intramuscular, right arm). In JUN-2023, an unknown time after receiving Shingrix, the patient experienced inappropriate age at vaccine administration (Verbatim: 39 year old patient her first dose of Shingrix in June 2023). In OCT-2023, the patient experienced shingles (Verbatim: Shingles Mild case in OCT-2023). In MAR-2024, the patient experienced shingles (Verbatim: Shingles MAR 2024). In NOV-2024, the patient experienced shingles (Verbatim: Shingles NOV 2024) and covid-19 (Verbatim: COVID-19). In APR-2025, the patient experienced shingles (Verbatim: currently has shingles now, APR 2025). The patient was treated with aciclovir sodium (Acyclovir). In NOV-2024, the outcome of the covid-19 was resolved. The outcome of the shingles, shingles and shingles were not reported and the outcome of the shingles was not resolved and the outcome of the inappropriate age at vaccine administration was not applicable. It was unknown if the reporter considered the shingles, shingles, shingles, shingles and covid-19 to be related to Shingrix. It was unknown if the company considered the shingles, shingles, shingles, shingles and covid-19 to be related to Shingrix. Additional Information: GSK Receipt Date: 04-APR-2025 The patient self-reported this case. The patient received her first dose of Shingrix in June 2023 (no specific date provided) and she never received her second dose. The patient had shingles four times since receiving her first dose of Shingrix at the following times in October 2023 (Mild case), March 2024, November 2024 and she currently had shingles now in April 2025. The patient last two times she had shingles in March 2024 and November 2024 were the worst she ever had it. The patient had shingles 11 times in her life, with the first time when she was 19 years old. The patient stated that all four cases of shingles since her first dose of Shingrix presented on the right side of her tailbone or butt area and she took Acyclovir in November 2024 for her shingles outbreak because she also had COVID at that time (no specific dates provided). The patient states the Acyclovir made her nauseous and was so she no longer took antivirals for her shingles outbreaks The patient received 1st dose of Shingrix at an inappropriate age, which led to inappropriate age at vaccine administration.

Medical history

Medical History/Concurrent Conditions: Shingles (had shingles 11 times with the first time at 19 years old)